Archive Results

  • BioLamina AB expands production and office space to meet the fast-growing customer demand

     Stockholm September 14th, 2021 BioLamina AB expands production and office space to meet the fast-growing customer demand   BioLamina (Stockholm) is […]
  • BioLamina AB and Inventia Life Science partner to advance cell matrices for complex 3D cell models

     Stockholm August 24th, 2021 BioLamina AB and Inventia Life Science partner to advance cell matrices for complex 3D cell models […]
  • BioLamina AB launches new website

    June 22, 2021 BioLamina AB launches new website BioLamina (Stockholm) is thrilled to announce the launch of its new website, […]
  • BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of human diseases

    June 9, 2021 BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of […]
  • Biolamina and Spiber Technologies sign exclusive sales and marketing deal for unique Biosilk products

    June 18, 2019 Biolamina and Spiber Technologies sign exclusive sales and marketingdeal for unique Biosilk products BioLamina has for the […]
  • Stay updated on the latest publications and offers by signing up to the BioLamina Newsletter

    Stay updated on the latest publications and offers by signing up to the BioLamina Newsletter Past newsletters May 2021January 2021December 2020September […]
  • BioLamina and Novo Nordisk partner to advance stem cell based therapies for three common medical conditions

    May 16, 2018 BioLamina and Novo Nordisk partner to advance stem cell based therapies for three common medical conditions BioLamina […]
  • BioLamina and partners aim to develop new methods to differentiate unlimited amounts of NK-cells to fight cancer

    November 7, 2018 BioLamina and partners aim to develop new methods to differentiate unlimited amounts of NK-cells to fight cancer […]
  • BioLamina announces an OEM partnership with Cellink for the development of biologically relevant bioink products for bioprinting

    August 27, 2018 BioLamina announces an OEM partnership with Cellink for the development of biologically relevant bioink products for bioprinting […]
  • Webcast series: Rising stars

    Human Embryonic Stem Cells for Treatment of Retinal Degeneration In this webcast, Sandra describes how she and her colleagues have paved the […]